8 March 2022

Martijn Verdoes, group leader Chemical Immunology at the department of Tumor Immunology, has been awarded an ERC Proof of Concept (PoC) Grant. The ERC PoC Grants are designed to support ERC grantees with the commercial or societal application of the results of their funded research.

The project with the title “CNECT-VAX, C- and N-terminal Epitope Conjugate immune cell Targeted Vaccines” aims to validate the technical and commercial feasibility of a new cancer vaccine platform that uses nanobodies targeting dendritic cells (DCs) to co-deliver antigens in vivo. The project is based on a novel molecular vaccine strategy that effectively delivers target antigens to DCs to concomitantly induce robust and synergistic CD4+ and CD8+ T cell responses.

The ERC Proof of Concept is a part of the European Research Council (ERC) grants. The grants recognize the best ideas and talents, and thereby aiming to maximize the value of the excellent research that the ERC funds, and funding further work to verify the innovation potential of ideas arising from ERC-funded projects. They are very competitive, and requires an outstanding track record as an important factor of success.

Official press release ERC Europe: https://erc.europa.eu/news/erc-2021-proof-of-concept-grants-results 

Related news items

Rubicon grants awarded to three RIMLS researchers

19 April 2022 Three researchers have received Rubicon funding from NWO/ZonMw. This will enable Elke Muntjewerff, Laura de Vries and Laurens van de Wiel to do research at a foreign research institute for the next two years. read more

New genetic defect links cell biology and protein glycosylation

10 November 2021 Peter Linders, Dirk Lefeber and Geert van den Bogaart together with international colleagues have recently reported on novel cell biological insights, by identifying a genetic disorder in syntaxin-5 which allowed to unravel a new mechanism regulating intracellular transportation. read more

RIMLS awards call for nominations

19 October 2021 RIMLS awards several prizes to stimulate and honor our (young) researchers. Upcoming awards are Supervisor of the Year, Best Master Thesis, Best Publication, Best Image and more. Send your nominations now before 24 November 2021. read more

Miniaturized microfluidic platform for automated epigenetic profiling

6 May 2021 Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies. read more

RIMLS online award ceremony proudly presenting the winners

13 January 2021 In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.  read more

NWO ENW KLEIN grant awarded to Koen van den Dries and Michiel Vermeulen

22 December 2020 Koen van den Dries will investigate the molecular mechanisms of actin isoform usage in cancer cell migrations. Michiel Vermeulen will search for proteins that interact with adenosine diphosphate ribose chains and play a role in the cellular response to damage to DNA. read more